Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Here's Why You Should Retain CNO Financial (CNO) Stock

Published 05/22/2017, 08:47 AM
Updated 07/09/2023, 06:31 AM

Shares of CNO Financial Group, Inc. (NYSE:CNO) have gained 5.9% year to date, outpacing the Zacks categorized Multi Line Insurance industry’s increase of 0.686%. This clearly reflects shareholders’ confidence on the stock. Also, the company’s prudent capital deployment initiatives like share repurchases and dividend payments have supported growth.

During 2016, the company bought back shares worth $203 million and paid dividends of $55 million. In the first quarter of 2017, the company repurchased shares worth $43 million and paid dividends of $14 million. Additionally, in May 2017, CNO Financial raised its dividend by 14% and its board approved an additional $300 million to repurchase the outstanding common stock.

CNO Financial’s Washington National segment has been delivering strong performance over the last few quarters.In the recently reported first quarter, the segment’s total collected premiums grew 5% year over year on higher sales of supplemental health products. CNO Financial also plans to restructure its field leadership and introduce technologically updated products to boost agent productivity in this particular segment.

The company’s liquidity supports investment in agent productivity, geographic expansion, product launches, worksite platform distribution as well as enhancement of operating efficiencies and customer retention. In 2016, it acquired Tennenbaum Capital Partners, which substantially boosted its return on investment. Recently, it also launched guaranteed lifetime income annuity. The company’s regular investments across the enterprise have significantly enhanced its operational efficiency.

The stock appears to be undervalued. CNO Financial’s Price to Cash flow (PCF) ratio of 4.93 is lower than the industry level of 6.69. Another important valuation ratio – Price to Sales (PS) – is 0.86, which compares favorably with the industry average of 1.02.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

However, CNO Financial’s over dependence on debt is a major concern as it has been raising borrowing cost and limiting the company’s profitability. For 2016, interest expenses grew 22% year over year , followed by a 50% increase in the first quarter of 2017. Consolidated risk-based capital ratio was estimated at 446% as of Mar 31, 2017, reflecting estimated consolidated statutory operating earnings of $70 million and dividends to the holding company of $128.4 million.

Owing to its small market share, CNO Financial faces tremendous challenges in some product lines, such as life insurance and fixed annuities. Despite holding the ninth position in the list of the top writers in the individual long-term care insurance business, the company has been unable to grow it market share above 3%. This may limit business opportunities for it.

Zacks Rank and Stocks to Consider

CNO Financial presently carries a Zacks Rank #3 (Hold).

Some better-ranked multi line insurers are Cigna Corporation (NYSE:CI) , James River Group Holdings, Ltd. (NASDAQ:JRVR) and Torchmark Corporation (NYSE:TMK) . All of the stocks carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Cigna’s earnings beat estimates in three of the last four quarters with an average earnings surprise of 1.35%.

Another multi line insurer, James River Group, delivered positive earnings surprises in all of the the last four quarters with an average positive surprise of 9.47%.

Torchmark surpassed expectations in all of the last four quarters with an average beat of 2.01%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks' 2017 IPO Watch List

Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time.

One has driven from 0 to a $68 billion valuation in 8 years. Four others are a little less obvious but already show jaw-dropping growth. Download this IPO Watch List today for free >>



Torchmark Corporation (TMK): Free Stock Analysis Report

Cigna Corporation (CI): Free Stock Analysis Report

CNO Financial Group, Inc. (CNO): Free Stock Analysis Report

James River Group Holdings, Ltd. (JRVR): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.